From smog to UV to the foods we eat, skin is under attack—from regulators, too. The U.S. Food and Drug Administration is sending out warning letters at a fast pace, causing headaches and delays for formulators and their suppliers. To find out what can appear on labels and in advertising messages, be sure to attend Happi’s 5th Anti-Aging Conference & Tabletop Exhibition, which will be held Sep. 20 & 21, 2016 at the Hyatt Regency, New Brunswick, NJ. Georgia Ravitz, Esq., partner Arent Fox, will lead a roundtable featuring experts from FDA, NAD and FTC to discuss the latest regulatory issues impacting the anti-aging category.

The two-day event will include presentations by leading formulators, dermatologists and regulators in the anti-aging space. For example, Chérie M. Ditre, MD, will detail the latest anti-aging technologies and how they work. Aanand N. Geria, MD, will explain the important role that retinoids play in keeping skin young. Other speakers and topics include:

• Dr. Joseph A. Schwarcz, PhD, McGill University, “Aging: Fact & Fancy;”
• Dr. Shyam Gupta, PhD, “How to Manage Cellular Degeneration and How Gene Expression Enhances the Efficacy of Anti-Aging Products;”
• Dr. Robb Akridge, PhD, co-founder and president, Clarisonic, “The Benefits of Using Devices and Formulating Skin Care Products for Devices;”
• Dr. Estee Williams, MD, “Skin Aging—The Causation Factors;”
• Raqiyyah Pippins, Esq, “How to Navigate the Regulatory Landscape;”
• Seemal N. Desai, MD “Shedding Light on Skin Lightener Trends;”
• Jennifer Stansbury, CEO, The Benchmarking Company, “Clinical and Consumer Claims – When, How and Why to Use Each to Bolster Sell-Through and Mitigate Legal Risk;”
• Dr. Rebecca Lu, MD, “Cytokines, Growth Factors, Stem Cells, Peptides and Sirtuins. What Roles Do They Play in Anti-Aging?” and
• Mark Steele, CEO, Neostrata, “How a Little Company Changed the Face of Anti-Aging Around the World.”